Inventor · disambiguated record
Michael Su
Also filed as: SU MICHAEL · SU MICHAEL S · SU MICHAEL SHIN-SAN
29 granted patents·8 pending applications·705 citations·filing 1995–2025
97Inventor score
Files withVERTEX PHARMA21VOLASTRA THERAPEUTICS INC4BATCHELOR MARK JAMES2HOECHST MARION ROUSSEL INC2HONGENE BIOTECH CORP2
Top patents by PatentIndex Score
37 records- 0194US7790713B2Inhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 2007·Granted Sep 7, 2010·24 cites·20 claims
- 0293US6423840B1Inhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 2001·Granted Jul 23, 2002·40 cites·10 claims
- 0392US9487451B2Endophytic yeast strains, methods for ethanol and xylitol production, methods for biological nitrogen fixation, and a genetic source for improvement of industrial strainsUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2014·Granted Nov 8, 2016·27 cites·14 claims
- 0492US6204261B1Inhibitors of interleukin-1β Converting enzyme inhibitorsVERTEX PHARMA·Filed 1996·Granted Mar 20, 2001·80 cites·34 claims
- 0591US8119631B2Inhibitors of interleukin-1β converting enzymeBATCHELOR MARK JAMES·Filed 2010·Granted Feb 21, 2012·24 cites·15 claims
- 0691US6162613AMethods for designing inhibitors of serine/threonine-kinases and tyrosine kinasesVERTEX PHARMA·Filed 1998·Granted Dec 19, 2000·95 cites·9 claims
- 0787US7365072B2Inhibitors of p38VERTEX PHARMA·Filed 2005·Granted Apr 29, 2008·7 cites·23 claims
- 0885US6258948B1Inhibitors of Interleukin-1β converting enzymeVERTEX PHARMA·Filed 1999·Granted Jul 10, 2001·42 cites·46 claims
- 0985US5861267AMethods, nucleotide sequences and host cells for assaying exogenous and endogenous protease activityVERTEX PHARMA·Filed 1995·Granted Jan 19, 1999·80 cites·21 claims
- 1083US5780484AMethods for stimulating neurite growth with piperidine compoundsVERTEX PHARMA·Filed 1996·Granted Jul 14, 1998·62 cites·14 claims
- 1182US7383135B1Methods of designing inhibitors for JNK kinasesVERTEX PHARMA·Filed 2000·Granted Jun 3, 2008·9 cites·4 claims
- 1282US5840736AMethods and compositions for stimulating neurite growthVERTEX PHARMA·Filed 1996·Granted Nov 24, 1998·46 cites·26 claims
- 1381US5985863ACompositions and methods for decreasing IGIF and IFN-γ production by administering an ICE inhibitorVERTEX PHARMA·Filed 1996·Granted Nov 16, 1999·64 cites·17 claims
- 1480US7205305B2Inhibitors of p38VERTEX PHARMA·Filed 2003·Granted Apr 17, 2007·9 cites·19 claims
- 1579US5811434AMethods and compositions for stimulating neurite growthVERTEX PHARMA·Filed 1996·Granted Sep 22, 1998·48 cites·31 claims
- 1677US11780849B2Imino sulfanone inhibitors of ENPP1VOLASTRA THERAPEUTICS INC·Filed 2021·Granted Oct 10, 2023·1 cites·10 claims
- 1776US2024287120A1Functionalized n-acetylgalactosamine analogsHONGENE BIOTECH CORP·Filed 2024·Application pending·0 cites
- 1875US8338412B2Inhibitors of P38BEMIS GUY W·Filed 2011·Granted Dec 25, 2012·3 cites·19 claims
- 1974US2024376113A1Heterocyclic inhibitors of enpp1VOLASTRA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2073US8728781B2Endophytic yeast strains, methods for ethanol and xylitol production, methods for biological nitrogen fixation, and a genetic source for improvement of industrial strainsDOTY SHARON L·Filed 2010·Granted May 20, 2014·3 cites·6 claims
- 2173US6284778B1Methods and compositions for stimulating neurite growthVERTEX PHARMA·Filed 2000·Granted Sep 4, 2001·5 cites·7 claims
- 2272US11993626B2Functionalized N-acetylgalactosamine analogsHONGENE BIOTECH CORP·Filed 2022·Granted May 28, 2024·0 cites·31 claims
- 2372US6849716B1Methods for designing inhibitors of serine/threonine kinases and tyrosine kinasesVERTEX PHARMA·Filed 2000·Granted Feb 1, 2005·7 cites·2 claims
- 2469US8002891B2Crystallization of C-Jun N-Terminal Kinase 3 (JNK3)VERTEX PHARMA·Filed 2008·Granted Aug 23, 2011·0 cites·5 claims
- 2566US7951809B2Inhibitors of p38VERTEX PHARMA·Filed 2008·Granted May 31, 2011·0 cites·14 claims
- 2665US6608060B1Inhibitors of p38VERTEX PHARMA·Filed 1999·Granted Aug 19, 2003·15 cites·27 claims
- 2765US2025368654A1Heterocyclic inhibitors of enpp1VOLASTRA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2863US2004259166A1Methods for designing inhibitors of serine/threonine kinases and tyrosine kinasesFiled 2004·Application pending·0 cites
- 2962US12091412B2Heterocyclic inhibitors of ENPP1VOLASTRA THERAPEUTICS INC·Filed 2021·Granted Sep 17, 2024·0 cites·24 claims
- 3055US6172086B1Methods and compositions for stimulating neurite growthVERTEX PHARMA·Filed 1998·Granted Jan 9, 2001·10 cites·15 claims
- 3149US2003165899A1Methods for designing inhibitors of serine/threonine kinases and tyrosine kinasesVERTEX PHARMA·Filed 2002·Application pending·0 cites
- 3240US2003097669A1Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of Erk-5Filed 2001·Application pending·0 cites
- 3337US2012165319A1Inhibitors of interleukin-1 beta converting enzymeBATCHELOR MARK JAMES·Filed 2011·Application pending·0 cites
- 3436US2003163834A1Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of Erk-5Filed 2001·Application pending·0 cites
- 3533US6225350B1Butyrate prodrugs derived from lactic acidVERTEX PHARMA·Filed 1999·Granted May 1, 2001·2 cites·6 claims
- 3632US6020477ADNA sequences coding for the human proteins Tx and Ty related to the interleukin-1β converting enzymeHOECHST MARION ROUSSEL INC·Filed 1995·Granted Feb 1, 2000·2 cites·2 claims
- 3726US6180386B1DNA sequences coding for the human proteins Tx and Ty related to the interleukin-1beta converting enzymeHOECHST MARION ROUSSEL INC·Filed 1999·Granted Jan 30, 2001·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Michael Su files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →